QI
BIO icon

Qtron Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Qtron Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-559
Closed -$417K – 333
2021
Q3 		$417K Sell
559
-483
-46% -$362K 0.11% 239
2021
Q2 		$671K Hold
1,042
– – 0.17% 180
2021
Q1 		$595K Hold
1,042
– – 0.17% 170
2020
Q4 		$607K Buy
1,042
+170
+19% +$96.8K 0.16% 158
2020
Q3 		$449K Sell
872
-110
-11% -$55.7K 0.16% 158
2020
Q2 		$443K Buy
+982
New +$433K 0.18% 147

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Qtron Investments's BIO Position: Q4 2021 in Review

Qtron Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 559 shares — an estimated $417K sold.

Qtron Investments first reported a position in BIO in Q2 2020 and held it in 6 quarters. The position peaked at $671K in Q2 2021. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • Qtron Investments reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • Qtron Investments sold 559 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $417K.
  • Qtron Investments first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 6 quarters.
  • Qtron Investments's Bio-Rad Laboratories Class A position peaked at $671K in Q2 2021.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Qtron Investments's 13F filing for Q4 2021, filed 16 Feb 2022.